ArticleNeoplasia (New York, N.Y.)2009

A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer.

Ya-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.